在脑静脉血栓症中血栓的组成
Ghil Schwarz1, Angelo Cascio Rizzo1, Martina Di Como2
1Department of Neurology and Stroke Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Stroke research and treatment
|July 1, 2025
概括
大脑静脉血栓 (CVT) 血栓较大,含有更多的红细胞 (RBC),而不是急性缺血性中风 (AIS) 血栓. 这种组成与CT密度相关,为CVT病理生理学提供了洞察力.
科学领域:
- 神经学 神经学
- 病理生理学 病理生理学
- 历史学 历史学 历史学
背景情况:
- 对瘤组织学分析有助于理解病理生理学.
- 大脑静脉血栓 (CVT) 需要进一步调查其独特的血栓特征.
研究的目的:
- 为了分析内血管治疗 (EVT) 恢复的CVT瘤.
- 为了比较CVT血栓与急性缺血性中风 (AIS) 血栓.
- 为了将CVT血栓组成与计算机断层扫描 (CT) 密度相关联.
主要方法:
- 追溯的5个CVT和10个AIS病例的案例系列,用EVT治疗.
- 组织学染色 (H&E,皮克罗·马洛里,普鲁士蓝) 和免疫组织化学 (CD61,MPO,CD3,CD20,CD34,CD68,citH3).
- 血栓成分的量化和相对CT密度 (rHU) 的计算.
主要成果:
- 与AIS血栓相比,CVT血栓显著更大 (185.6mm2对21.8mm2) 和纤维素含量较低 (16.6%对46.5%).
- CVT血栓富含红细胞 (RBC) 并显示早期组织的迹象.
- 低纤维素含量和高的红细胞与纤维素比率与增加的CT密度 (rHU) 有显著的相关性.
结论:
- 与AIS血栓相比,CVT血栓的特点是尺寸更大,红细胞含量更高,纤维素较低.
- 血栓组成,特别是红细胞和纤维素水平,与CVT中的CT密度相关.
- 这些发现为CVT病理生理学提供了新的见解,需要进一步验证.
相关概念视频
Venous Thrombosis I: Introduction
46
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
46
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
41
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
41
Venous Thrombosis III: Interprofessional Care
27
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
27
Anticoagulant Drugs: Low-Molecular-Weight Heparins
921
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
921
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
Extrinsic and Intrinsic Pathways of Hemostasis
9.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.3K


